|
1
|
Angulo JF, Moreau PL, Maunoury R, Laporte
J, Hill AM, Bertolotti R and Devoret R: KIN, a mammalian nuclear
protein immunologically related to E. coli RecA protein. Mutat Res.
217:123–134. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Seetharam A and Stuart GW: A study on the
distribution of 37 well conserved families of C2H2 zinc finger
genes in eukaryotes. BMC Genomics. 14:4202013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Angulo JF, Rouer E, Mazin A, Mattei MG,
Tissier A, Horellou P, Benarous R and Devoret R: Identification and
expression of the cDNA of KIN17, a zinc-finger gene located on
mouse chromosome 2, encoding a new DNA-binding protein. Nucleic
Acids Res. 19:5117–5123. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tissier A, Kannouche P, Mauffrey P,
Allemand I, Frelat G, Devoret R and Angulo JF: Molecular cloning
and characterization of the mouse Kin17 gene coding for a Zn-finger
protein that preferentially recognizes bent DNA. Genomics.
38:238–242. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kannouche P, Mauffrey P, Pinon-Lataillade
G, Mattei MG, Sarasin A, Daya-Grosjean L and Angulo JF: Molecular
cloning and characterization of the human KIN17 cDNA encoding a
component of the UVC response that is conserved among metazoans.
Carcinogenesis. 21:1701–1710. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tissier A, Kannouche P, Biard DS,
Timchenko T, Mazin A, Araneda S, Allemand I, Mauffrey P, Frelat G
and Angulo JF: The mouse Kin-17 gene codes for a new protein
involved in DNA transactions and is akin to the bacterial RecA
protein. Biochimie. 77:854–860. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Angulo JF, Rouer E, Benarous R and Devoret
R: Identification of a mouse cDNA fragment whose expressed
polypeptide reacts with anti-recA antibodies. Biochimie.
73:251–256. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Biard DS, Miccoli L, Despras E, Frobert Y,
Creminon C and Angulo JF: Ionizing radiation triggers
chromatin-bound kin17 complex formation in human cells. J Biol
Chem. 277:19156–19165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pattaro Júnior JR, Caruso ÍP, de Lima Neto
QA, Duarte Junior FF, Dos Santos Rando F, Gerhardt ECM, Fernandez
MA and Seixas FAV: Biophysical characterization and molecular
phylogeny of human KIN protein. Eur Biophys J. 48:645–657. 2019.
View Article : Google Scholar
|
|
10
|
Mazin A, Milot E, Devoret R and Chartrand
P: KIN17, a mouse nuclear protein, binds to bent DNA fragments that
are found at illegitimate recombination junctions in mammalian
cells. Mol Gen Genet. 244:435–438. 1994. View Article : Google Scholar
|
|
11
|
Mazin A, Timchenko T, Ménissier-de Murcia
J, Schreiber V, Angulo JF, de Murcia G and Devoret R: Kin17, a
mouse nuclear zinc finger protein that binds preferentially to
curved DNA. Nucleic Acids Res. 22:4335–4341. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
le Maire A, Schiltz M, Stura EA,
Pinon-Lataillade G, Couprie J, Moutiez M, Gondry M, Angulo JF and
Zinn-Justin S: A tandem of SH3-like domains participates in RNA
binding in KIN17, a human protein activated in response to
genotoxics. J Mol Biol. 364:764–776. 2006. View Article : Google Scholar
|
|
13
|
Kannouche P, Pinon-Lataillade G, Tissier
A, Chevalier-Lagente O, Sarasin A, Mezzina M and Angulo JF: The
nuclear concentration of kin17, a mouse protein that binds to
curved DNA, increases during cell proliferation and after UV
irradiation. Carcinogenesis. 19:781–789. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Masson C, Menaa F, Pinon-Lataillade G,
Frobert Y, Chevillard S, Radicella JP, Sarasin A and Angulo JF:
Global genome repair is required to activate KIN17, a
UVC-responsive gene involved in DNA replication. Proc Natl Acad Sci
USA. 100:616–621. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Biard DS, Saintigny Y, Maratrat M, Paris
F, Martin M and Angulo JF: Enhanced expression of the Kin17 protein
immediately after low doses of ionizing radiation. Radiat Res.
147:442–450. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masson C, Menaa F, Pinon-Lataillade G,
Frobert Y, Radicella JP and Angulo JF: Identification of KIN
(KIN17), a human gene encoding a nuclear DNA-binding protein, as a
novel component of the TP53-independent response to ionizing
radiation. Radiat Res. 156((5 Pt 1)): 535–544. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blattner C, Kannouche P, Litfin M, Bender
K, Rahmsdorf HJ, Angulo JF and Herrlich P: UV–Induced stabilization
of c-fos and other short-lived mRNAs. Mol Cell Biol. 20:3616–3625.
2000. View Article : Google Scholar
|
|
18
|
Johmura Y, Yamashita E, Shimada M,
Nakanishi K and Nakanishi M: Defective DNA repair increases
susceptibility to senescence through extension of Chk1-mediated G2
checkpoint activation. Sci Rep. 6:311942016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Trevino V: Integrative genomic analysis
identifies associations of molecular alterations to APOBEC and
BRCA1/2 mutational signatures in breast cancer. Mol Genet Genomic
Med. 7:e8102019. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Elshimali YI, Wu Y, Khaddour H, Wu Y,
Gradinaru D, Sukhija H, Chung SS and Vadgama JV: Optimization of
cancer treatment through overcoming drug resistance. J Cancer Res
Oncobiol. 1:1072018.
|
|
21
|
Phadnis N, Hyppa RW and Smith GR: New and
old ways to control meiotic recombination. Trends Genet.
27:411–421. 2011. View Article : Google Scholar
|
|
22
|
Biard DS: Untangling the relationships
between DNA repair pathways by silencing more than 20 DNA repair
genes in human stable clones. Nucleic Acids Res. 35:3535–3550.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Le MX, Haddad D, Ling AK, Li C, So CC,
Chopra A, Hu R, Angulo JF, Moffat J and Martin A: Kin17 facilitates
multiple double-strand break repair pathways that govern B cell
class switching. Sci Rep. 6:372152016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Despras E, Miccoli L, Créminon C,
Rouillard D, Angulo JF and Biard DS: Depletion of KIN17, a human
DNA replication protein, increases the radiosensitivity of RKO
cells. Radiat Res. 159:748–758. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Miccoli L, Biard DS, Créminon C and Angulo
JF: Human kin17 protein directly interacts with the simian virus 40
large T antigen and inhibits DNA replication. Cancer Res.
62:5425–5435. 2002.PubMed/NCBI
|
|
26
|
Miccoli L, Frouin I, Novac O, Di Paola D,
Harper F, Zannis-Hadjopoulos M, Maga G, Biard DS and Angulo JF: The
human stress-activated protein kin17 belongs to the multiprotein
DNA replication complex and associates in vivo with mammalian
replication origins. Mol Cell Biol. 25:3814–3830. 2005. View Article : Google Scholar
|
|
27
|
Miccoli L, Biard DS, Frouin I, Harper F,
Maga G and Angulo JF: Selective interactions of human kin17 and RPA
proteins with chromatin and the nuclear matrix in a DNA damage- and
cell cycle-regulated manner. Nucleic Acids Res. 31:4162–4175. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Biard DS, Miccoli L, Despras E, Harper F,
Pichard E, Créminon C and Angulo JF: Participation of kin17 protein
in replication factories and in other DNA transactions mediated by
high molecular weight nuclear complexes. Mol Cancer Res. 1:519–531.
2003.PubMed/NCBI
|
|
29
|
Gaspar VP, Ramos AC, Cloutier P, Pattaro
Junior JR, Duarte Junior FF, Bouchard A, Seixas FAV, Coulombe B and
Fernandez MA: Interactome analysis of KIN (Kin17) shows new
functions of this protein. Curr Issues Mol Biol. 43:767–781. 2021.
View Article : Google Scholar
|
|
30
|
Cloutier P, Lavallée-Adam M, Faubert D,
Blanchette M and Coulombe B: Methylation of the DNA/RNA-binding
protein Kin17 by METTL22 affects its association with chromatin. J
Proteomics. 100:115–124. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cloutier P, Lavallée-Adam M, Faubert D,
Blanchette M and Coulombe B: A newly uncovered group of distantly
related lysine methyltransferases preferentially interact with
molecular chaperones to regulate their activity. PLoS Genet.
9:e10032102013. View Article : Google Scholar
|
|
32
|
Huttlin EL, Bruckner RJ, Paulo JA, Cannon
JR, Ting L, Baltier K, Colby G, Gebreab F, Gygi MP, Parzen H, et
al: Architecture of the human interactome defines protein
communities and disease networks. Nature. 545:505–509. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Luo M: Chemical and biochemical
perspectives of protein lysine methylation. Chem Rev.
118:6656–6705. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Malecki J, Aileni VK, Ho AYY, Schwarz J,
Moen A, Sørensen V, Nilges BS, Jakobsson ME, Leidel SA and Falnes
PØ: The novel lysine specific methyltransferase METTL21B affects
mRNA translation through inducible and dynamic methylation of
Lys-165 in human eukaryotic elongation factor 1 alpha (eEF1A).
Nucleic Acids Res. 45:4370–4389. 2017.PubMed/NCBI
|
|
35
|
Fusser M, Kernstock S, Aileni VK,
Egge-Jacobsen W, Falnes PØ and Klungland A: Lysine methylation of
the valosin-containing protein (VCP) is dispensable for development
and survival of mice. PLoS One. 10:e01414722015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jakobsson ME, Davydova E, Małecki J, Moen
A and Falnes PØ: Saccharomyces cerevisiae eukaryotic elongation
factor 1A (eEF1A) is methylated at Lys-390 by a METTL21-Like
Methyltransferase. PLoS One. 10:e01314262015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang L, Lu Q and Chang C: Epigenetics in
health and disease. Adv Exp Med Biol. 1253:3–55. 2020. View Article : Google Scholar
|
|
38
|
Zhang Y, Sun Z, Jia J, Du T, Zhang N, Tang
Y, Fang Y and Fang D: Overview of histone modification. Adv Exp Med
Biol. 1283:1–16. 2021. View Article : Google Scholar
|
|
39
|
Hyun K, Jeon J, Park K and Kim J: Writing,
erasing and reading histone lysine methylations. Exp Mol Med.
49:e3242017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Liu Y, Liu K, Qin S, Xu C and Min J:
Epigenetic targets and drug discovery: Part 1: Histone methylation.
Pharmacol Ther. 143:275–294. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kimura H: Histone modifications for human
epigenome analysis. J Hum Genet. 58:439–445. 2013. View Article : Google Scholar
|
|
42
|
Gong F and Miller KM: Histone methylation
and the DNA damage response. Mutat Res Rev Mutat Res. 780:37–47.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Trievel RC: Structure and function of
histone methyltransferases. Crit Rev Eukaryot Gene Expr.
14:147–169. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yang W and Ernst P: Distinct functions of
histone H3, lysine 4 methyltransferases in normal and malignant
hematopoiesis. Curr Opin Hematol. 24:322–328. 2017. View Article : Google Scholar
|
|
45
|
Wang MY, Liow P, Guzman MIT and Qi J:
Exploring methods of targeting histone methyltransferases and their
applications in cancer therapeutics. ACS Chem Biol. 17:744–755.
2022. View Article : Google Scholar
|
|
46
|
Martinez NJ and Simeonov A: Cell-based
assays to support the profiling of small molecules with histone
methyltransferase and demethylase modulatory activity. Drug Discov
Today Technol. 18:9–17. 2015. View Article : Google Scholar
|
|
47
|
Dawson MA and Kouzarides T: Cancer
epigenetics: From mechanism to therapy. Cell. 150:12–27. 2012.
View Article : Google Scholar
|
|
48
|
Ilango S, Paital B, Jayachandran P, Padma
PR and Nirmaladevi R: Epigenetic alterations in cancer. Front
Biosci (Landmark Ed). 25:1058–1109. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Okugawa Y, Grady WM and Goel A: Epigenetic
alterations in colorectal cancer: Emerging biomarkers.
Gastroenterology. 149:1204–1225.e12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Darılmaz Yüce G and Ortaç Ersoy E: Lung
cancer and epigenetic modifications. Tuberk Toraks. 64:163–170.
2016.(In Turkish). View Article : Google Scholar
|
|
51
|
Esteller M: Cancer epigenomics: DNA
methylomes and histone-modification maps. Nat Rev Genet. 8:286–298.
2007. View Article : Google Scholar
|
|
52
|
Sun L, Zhang H and Gao P: Metabolic
reprogramming and epigenetic modifications on the path to cancer.
Protein Cell. 13:877–919. 2022. View Article : Google Scholar
|
|
53
|
Jones PA, Issa JP and Baylin S: Targeting
the cancer epigenome for therapy. Nat Rev Genet. 17:630–641. 2016.
View Article : Google Scholar
|
|
54
|
Park JW and Han JW: Targeting epigenetics
for cancer therapy. Arch Pharm Res. 42:159–170. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang P and Zhang M: Epigenetic
alterations and advancement of treatment in peripheral T-cell
lymphoma. Clin Epigenetics. 12:1692020. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Carlier L, Couprie J, le Maire A,
Guilhaudis L, Milazzo-Segalas I, Courçon M, Moutiez M, Gondry M,
Davoust D, Gilquin B and Zinn-Justin S: Solution structure of the
region 51–160 of human KIN17 reveals an atypical winged helix
domain. Protein Sci. 16:2750–2755. 2007. View Article : Google Scholar
|
|
57
|
Ruan L, Jiang Q and Zhang H: Relationships
of kin17 protein expression with clinical features and prognosis of
colorectal cancer. Transl Cancer Res. 7:2018. View Article : Google Scholar
|
|
58
|
Ramos AC, Gaspar VP, Kelmer SM, Sellani
TA, Batista AG, De Lima Neto QA, Rodrigues EG and Fernandez MA: The
kin17 protein in murine melanoma cells. Int J Mol Sci.
16:27912–27920. 2015. View Article : Google Scholar
|
|
59
|
Zeng T, Gao H, Yu P, He H, Ouyang X, Deng
L and Zhang Y: Up-regulation of kin17 is essential for
proliferation of breast cancer. PLoS One. 6:e253432011. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Huang Q, Zahid KR, Chen J, Pang X, Zhong
M, Huang H, Pan W, Yin J, Raza U, Zeng J, et al: KIN17 promotes
tumor metastasis by activating EMT signaling in luminal-A breast
cancer. Thorac Cancer. 12:2013–2023. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Zhang Y, Gao H, Gao X, Huang S, Wu K, Yu
X, Yuan K and Zeng T: Elevated expression of Kin17 in cervical
cancer and its association with cancer cell proliferation and
invasion. Int J Gynecol Cancer. 27:628–633. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Marques LS, Violin VGA, Meireles LEF, de
Souza MVF, Mari NL, Damke GMZF, Damke E, Pereira MW, Mesquita CSS,
da Silva VRS and Consolaro MEL: Kin17 high expression as a
potential biomarker for high-grade cervical intraepithelial
neoplasia. Int J Gynaecol Obstet. 160:339–341. 2023. View Article : Google Scholar
|
|
63
|
Zhang Y, Huang S, Gao H, Wu K, Ouyang X,
Zhu Z, Yu X and Zeng T: Upregulation of KIN17 is associated with
non-small cell lung cancer invasiveness. Oncol Lett. 13:2274–2280.
2017. View Article : Google Scholar
|
|
64
|
Chen J, Xia Y, Peng Y, Wu S, Liu W, Zhang
H, Wang T, Yang Z, Zhao S and Zhao L: Analysis of the association
between KIN17 expression and the clinical features/prognosis of
epithelial ovarian cancer, and the effects of KIN17 in SKOV3 cells.
Oncol Lett. 21:4752021. View Article : Google Scholar
|
|
65
|
Dai Z, Huang Q, Huang X, Zhu C, Zahid KR,
Liu T, Li Q, Wu C, Peng M, Xiao X, et al: KIN17 promotes cell
migration and invasion through stimulating the TGF-β/Smad2 pathway
in hepatocellular carcinoma. Mol Carcinog. 62:369–384. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Gao X, Liu Z, Zhong M, Wu K, Zhang Y, Wang
H and Zeng T: Knockdown of DNA/RNA-binding protein KIN17 promotes
apoptosis of triple-negative breast cancer cells. Oncol Lett.
17:288–293. 2019.
|
|
67
|
Su B, Zhong M, Zhang Y, Wu K, Huang Q, Zhu
C and Zeng T: Deficiency of kin17 facilitates apoptosis of cervical
cancer cells by modulating caspase 3, PARP, and Bcl-2 Family
Proteins. J Oncol. 2022:31569682022. View Article : Google Scholar
|
|
68
|
Jiang QG, Xiong CF and Lv YX: Kin17
facilitates thyroid cancer cell proliferation, migration, and
invasion by activating p38 MAPK signaling pathway. Mol Cell
Biochem. 476:727–739. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Kou WZ, Xu SL, Wang Y, Wang LW, Wang L,
Chai XY and Hua QL: Expression of Kin17 promotes the proliferation
of hepatocellular carcinoma cells in vitro and in vivo. Oncol Lett.
8:1190–1194. 2014. View Article : Google Scholar
|
|
70
|
de Azambuja E, Cardoso F, de Castro G Jr,
Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D,
Piccart-Gebhart MJ and Paesmans M: Ki-67 as prognostic marker in
early breast cancer: A meta-analysis of published studies involving
12,155 patients. Br J Cancer. 96:1504–1513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Price JT, Tiganis T, Agarwal A, Djakiew D
and Thompson EW: Epidermal growth factor promotes MDA-MB-231 breast
cancer cell migration through a phosphatidylinositol 3′-kinase and
phospholipase C-dependent mechanism. Cancer Res. 59:5475–1578.
1999.PubMed/NCBI
|
|
72
|
Kolev V, Mandinova A, Guinea-Viniegra J,
Hu B, Lefort K, Lambertini C, Neel V, Dummer R, Wagner EF and Dotto
GP: EGFR signalling as a negative regulator of Notch1 gene
transcription and function in proliferating keratinocytes and
cancer. Nat Cell Biol. 10:902–911. 2008. View Article : Google Scholar
|
|
73
|
Zhong M, Liu Z, Wu K, Hong Z, Zhang Y, Qu
J, Zhu C, Ou Z and Zeng T: Kin17 knockdown suppresses the migration
and invasion of cervical cancer cells through NF-κB-Snail pathway.
Int J Clin Exp Pathol. 13:607–615. 2020.
|